Patrick O'Brien's most recent trade in Merchants Bancorp was a trade of 377 Common Stock done at an average price of $46.5 . Disclosure was reported to the exchange on Feb. 19, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Merchants Bancorp | Patrick D. O'Brien | Director | Grant, award, or other acquisition of securities at price $ 46.45 per share. | 19 Feb 2026 | 377 | 119,340 (0%) | 0% | 46.5 | 17,512 | Common Stock |
| Arrowhead Pharma Inc | Patrick O'Brien | COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2026 | 75,000 | 547,408 (0%) | 0% | 0 | Common Stock | |
| Arrowhead Pharma Inc | Patrick O'Brien | COO | Gift of securities by or to the insider at price $ 0.00 per share. | 06 Jan 2026 | 540 | 473,828 (0%) | 0% | 0 | Common Stock | |
| Arrowhead Pharma Inc | Patrick O'Brien | COO | Gift of securities by or to the insider at price $ 0.00 per share. | 06 Jan 2026 | 540 | 473,288 (0%) | 0% | 0 | Common Stock | |
| Arrowhead Pharma Inc | Patrick O'Brien | COO | Gift of securities by or to the insider at price $ 0.00 per share. | 06 Jan 2026 | 540 | 474,368 (0%) | 0% | 0 | Common Stock | |
| Arrowhead Pharma Inc | Patrick O'Brien | COO | Gift of securities by or to the insider at price $ 0.00 per share. | 06 Jan 2026 | 440 | 472,848 (0%) | 0% | 0 | Common Stock | |
| Arrowhead Pharma Inc | Patrick O'Brien | COO | Gift of securities by or to the insider at price $ 0.00 per share. | 06 Jan 2026 | 440 | 472,408 (0%) | 0% | 0 | Common Stock | |
| Arrowhead Pharma Inc | Patrick O'Brien | COO | Sale of securities on an exchange or to another person at price $ 62.96 per share. | 31 Dec 2025 | 13,451 | 500,418 (0%) | 0% | 63.0 | 846,875 | Common Stock |
| Arrowhead Pharma Inc | Patrick O'Brien | COO | Sale of securities on an exchange or to another person at price $ 63.84 per share. | 31 Dec 2025 | 11,842 | 488,576 (0%) | 0% | 63.8 | 755,993 | Common Stock |
| Arrowhead Pharma Inc | Patrick O'Brien | COO | Sale of securities on an exchange or to another person at price $ 62.23 per share. | 31 Dec 2025 | 6,164 | 513,869 (0%) | 0% | 62.2 | 383,586 | Common Stock |
| Arrowhead Pharma Inc | Patrick O'Brien | COO | Sale of securities on an exchange or to another person at price $ 62.91 per share. | 31 Dec 2025 | 5,873 | 477,290 (0%) | 0% | 62.9 | 369,470 | Common Stock |
| Arrowhead Pharma Inc | Patrick O'Brien | COO | Sale of securities on an exchange or to another person at price $ 61.20 per share. | 31 Dec 2025 | 4,368 | 520,033 (0%) | 0% | 61.2 | 267,322 | Common Stock |
| Arrowhead Pharma Inc | Patrick O'Brien | COO | Sale of securities on an exchange or to another person at price $ 64.44 per share. | 31 Dec 2025 | 2,700 | 485,876 (0%) | 0% | 64.4 | 173,988 | Common Stock |
| Arrowhead Pharma Inc | Patrick O'Brien | COO | Sale of securities on an exchange or to another person at price $ 64.04 per share. | 31 Dec 2025 | 2,336 | 474,954 (0%) | 0% | 64.0 | 149,597 | Common Stock |
| Arrowhead Pharma Inc | Patrick O'Brien | COO | Sale of securities on an exchange or to another person at price $ 66.01 per share. | 31 Dec 2025 | 900 | 484,976 (0%) | 0% | 66.0 | 59,409 | Common Stock |
| Arrowhead Pharma Inc | Patrick O'Brien | COO | Sale of securities on an exchange or to another person at price $ 62.25 per share. | 31 Dec 2025 | 900 | 483,163 (0%) | 0% | 62.3 | 56,025 | Common Stock |
| Arrowhead Pharma Inc | Patrick O'Brien | COO | Sale of securities on an exchange or to another person at price $ 61.12 per share. | 31 Dec 2025 | 600 | 484,063 (0%) | 0% | 61.1 | 36,672 | Common Stock |
| Arrowhead Pharma Inc | Patrick O'Brien | COO | Gift of securities by or to the insider at price $ 0.00 per share. | 31 Dec 2025 | 560 | 526,641 (0%) | 0% | 0 | Common Stock | |
| Arrowhead Pharma Inc | Patrick O'Brien | COO | Gift of securities by or to the insider at price $ 0.00 per share. | 31 Dec 2025 | 560 | 524,401 (0%) | 0% | 0 | Common Stock | |
| Arrowhead Pharma Inc | Patrick O'Brien | COO | Gift of securities by or to the insider at price $ 0.00 per share. | 31 Dec 2025 | 560 | 524,961 (0%) | 0% | 0 | Common Stock | |
| Arrowhead Pharma Inc | Patrick O'Brien | COO | Gift of securities by or to the insider at price $ 0.00 per share. | 31 Dec 2025 | 560 | 525,521 (0%) | 0% | 0 | Common Stock | |
| Arrowhead Pharma Inc | Patrick O'Brien | COO | Gift of securities by or to the insider at price $ 0.00 per share. | 31 Dec 2025 | 560 | 526,081 (0%) | 0% | 0 | Common Stock | |
| Arrowhead Pharma Inc | Patrick O'Brien | COO | Sale of securities on an exchange or to another person at price $ 68.00 per share. | 31 Dec 2025 | 313 | 484,663 (0%) | 0% | 68 | 21,284 | Common Stock |
| Arrowhead Pharma Inc | Patrick O'Brien | COO | Sale of securities on an exchange or to another person at price $ 68.00 per share. | 31 Dec 2025 | 46 | 474,908 (0%) | 0% | 68 | 3,128 | Common Stock |
| Cineverse Corp (Class A) | Patrick O'Brien | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Dec 2025 | 32,413 | 160,906 (0%) | 0% | 0 | Class A Common Stock | |
| Merchants Bancorp | Patrick D. O'Brien | Director | Grant, award, or other acquisition of securities at price $ 31.17 per share. | 19 Nov 2025 | 562 | 118,963 (0%) | 0% | 31.2 | 17,518 | Common Stock |
| Merchants Bancorp | Patrick D. O'Brien | Director | Grant, award, or other acquisition of securities at price $ 32.42 per share. | 21 Aug 2025 | 540 | 118,401 (0%) | 0% | 32.4 | 17,507 | Common Stock |
| Merchants Bancorp | Patrick D. O'Brien | Director | Grant, award, or other acquisition of securities at price $ 32.71 per share. | 15 May 2025 | 536 | 117,861 (0%) | 0% | 32.7 | 17,533 | Common Stock |
| Greenlight Cap Re Ltd (Class A) | Patrick O'Brien | Chief Operating Officer, SEE REMARKS | Sale of securities on an exchange or to another person at price $ 13.26 per share. | 12 May 2025 | 7,500 | 175,425 (0%) | 0% | 13.3 | 99,450 | ORDINARY SHARES |
| Greenlight Cap Re Ltd (Class A) | Patrick O'Brien | Chief Operating Officer, SEE REMARKS | Sale of securities on an exchange or to another person at price $ 13.48 per share. | 12 May 2025 | 7,500 | 182,925 (0%) | 0% | 13.5 | 101,100 | ORDINARY SHARES |
| Greenlight Cap Re Ltd (Class A) | Patrick O'Brien | Chief Operating Officer, SEE REMARKS | Sale of securities on an exchange or to another person at price $ 13.22 per share. | 12 May 2025 | 5,000 | 170,425 (0%) | 0% | 13.2 | 66,100 | ORDINARY SHARES |
| Greenlight Cap Re Ltd (Class A) | Patrick O'Brien | Chief Operating Officer, SEE REMARKS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Mar 2025 | 9,389 | 190,425 (0%) | 0% | 0 | ORDINARY SHARES | |
| Greenlight Cap Re Ltd (Class A) | Patrick O'Brien | Chief Operating Officer, SEE REMARKS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2025 | 29,277 | 181,036 (0%) | 0% | 0 | ORDINARY SHARES | |
| Merchants Bancorp | Patrick D. O'Brien | Director | Grant, award, or other acquisition of securities at price $ 42.82 per share. | 20 Feb 2025 | 409 | 117,325 (0%) | 0% | 42.8 | 17,513 | Common Stock |
| Arrowhead Pharma Inc | Patrick O'Brien | COO and General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2025 | 100,000 | 564,385 (0%) | 0% | 0 | Common Stock | |
| Arrowhead Pharma Inc | Patrick O'Brien | COO and General Counsel | Sale of securities on an exchange or to another person at price $ 19.69 per share. | 04 Jan 2025 | 19,658 | 544,727 (0%) | 0% | 19.7 | 387,066 | Common Stock |
| Arrowhead Pharma Inc | Patrick O'Brien | COO and General Counsel | Sale of securities on an exchange or to another person at price $ 20.10 per share. | 04 Jan 2025 | 9,526 | 535,201 (0%) | 0% | 20.1 | 191,473 | Common Stock |
| Arrowhead Pharma Inc | Patrick O'Brien | COO and General Counsel | Sale of securities on an exchange or to another person at price $ 19.69 per share. | 04 Jan 2025 | 8,000 | 527,201 (0%) | 0% | 19.7 | 157,520 | Common Stock |
| Cineverse Corp (Class A) | Patrick O'Brien | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2025 | 24,433 | 128,493 (0%) | 0% | 0 | Class A Common Stock | |
| Merchants Bancorp | Patrick D. O'Brien | Director | Sale or transfer of securities back to the company at price $ 25.00 per share. | 02 Jan 2025 | 6,000 | 0 | - | 25 | 150,000 | Series B depositary shares |
| Merchants Bancorp | Patrick D. O'Brien | Director | Sale or transfer of securities back to the company at price $ 25.00 per share. | 02 Jan 2025 | 4,000 | 0 | - | 25 | 100,000 | Series B Depositary Shares |
| Merchants Bancorp | Patrick D. O'Brien | Director | Purchase of securities on an exchange or from another person at price $ 25.00 per share. | 18 Nov 2024 | 40,000 | 40,000 | - | 25 | 1,000,000 | Series E Depositary Shares |
| Merchants Bancorp | Patrick D. O'Brien | Director | Purchase of securities on an exchange or from another person at price $ 25.00 per share. | 18 Nov 2024 | 40,000 | 40,000 | - | 25 | 1,000,000 | Series E Depositary Shares |
| Merchants Bancorp | Patrick D. O'Brien | Director | Grant, award, or other acquisition of securities at price $ 39.00 per share. | 18 Nov 2024 | 449 | 116,916 (0%) | 0% | 39 | 17,511 | Common Stock |
| Merchants Bancorp | Patrick D. O'Brien | Director | Grant, award, or other acquisition of securities at price $ 40.78 per share. | 15 Aug 2024 | 430 | 116,467 (0%) | 0% | 40.8 | 17,535 | Common Stock |
| Merchants Bancorp | Patrick D. O'Brien | Director | Sale or transfer of securities back to the company at price $ 25.00 per share. | 01 Apr 2024 | 80,000 | 0 | - | 25 | 2,000,000 | Series A Preferred Stock |
| Merchants Bancorp | Patrick D. O'Brien | Director | Sale or transfer of securities back to the company at price $ 25.00 per share. | 01 Apr 2024 | 23,000 | 0 | - | 25 | 575,000 | Series A Preferred Stock |
| Merchants Bancorp | Patrick D. O'Brien | Director | Grant, award, or other acquisition of securities at price $ 43.04 per share. | 01 Apr 2024 | 407 | 116,037 (0%) | 0% | 43.0 | 17,517 | Common Stock |
| Greenlight Cap Re Ltd (Class A) | Patrick O'Brien | SEE REMARKS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2024 | 8,489 | 151,759 (0%) | 0% | 0 | ORDINARY SHARES | |
| Merchants Bancorp | O'Brien D. Patrick | Director | Grant, award, or other acquisition of securities at price $ 38.75 per share. | 14 Feb 2024 | 452 | 115,630 (0%) | 0% | 38.8 | 17,515 | Common Stock |
| Arrowhead Pharma Inc | Patrick O'Brien | COO and General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2024 | 85,000 | 487,226 (0%) | 0% | 0 | Common Stock | |
| Arrowhead Pharma Inc | Patrick O'Brien | COO and General Counsel | Sale of securities on an exchange or to another person at price $ 35.65 per share. | 03 Jan 2024 | 12,741 | 464,385 (0%) | 0% | 35.7 | 454,217 | Common Stock |
| Arrowhead Pharma Inc | O'Brien Patrick | COO and General Counsel | Sale of securities on an exchange or to another person at price $ 34.99 per share. | 03 Jan 2024 | 8,200 | 477,126 (0%) | 0% | 35.0 | 286,918 | Common Stock |
| Arrowhead Pharma Inc | Patrick O'Brien | COO and General Counsel | Sale of securities on an exchange or to another person at price $ 31.83 per share. | 03 Jan 2024 | 3,849 | 408,726 (0%) | 0% | 31.8 | 122,514 | Common Stock |
| Arrowhead Pharma Inc | Patrick O'Brien | COO and General Counsel | Sale of securities on an exchange or to another person at price $ 32.52 per share. | 03 Jan 2024 | 2,800 | 405,926 (0%) | 0% | 32.5 | 91,056 | Common Stock |
| Arrowhead Pharma Inc | Patrick O'Brien | COO and General Counsel | Sale of securities on an exchange or to another person at price $ 33.99 per share. | 03 Jan 2024 | 1,900 | 485,326 (0%) | 0% | 34.0 | 64,581 | Common Stock |
| Arrowhead Pharma Inc | O'Brien Patrick | COO and General Counsel | Sale of securities on an exchange or to another person at price $ 32.65 per share. | 03 Jan 2024 | 1,700 | 403,826 (0%) | 0% | 32.7 | 55,505 | Common Stock |
| Arrowhead Pharma Inc | Patrick O'Brien | COO and General Counsel | Sale of securities on an exchange or to another person at price $ 32.63 per share. | 03 Jan 2024 | 1,600 | 402,226 (0%) | 0% | 32.6 | 52,208 | Common Stock |
| Arrowhead Pharma Inc | O'Brien Patrick | COO and General Counsel | Sale of securities on an exchange or to another person at price $ 33.41 per share. | 03 Jan 2024 | 400 | 405,526 (0%) | 0% | 33.4 | 13,364 | Common Stock |
| Cineverse Corp (Class A) | O'Brien Patrick | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Dec 2023 | 80,372 | 104,060 (0%) | 0% | 0 | Class A Common Stock | |
| Merchants Bancorp | Patrick D. O'Brien | Director | Grant, award, or other acquisition of securities at price $ 32.28 per share. | 15 Nov 2023 | 388 | 115,178 (0%) | 0% | 32.3 | 12,525 | Common Stock |
| Merchants Bancorp | Patrick D. O'Brien | Director | Grant, award, or other acquisition of securities at price $ 30.10 per share. | 17 Aug 2023 | 416 | 114,790 (0%) | 0% | 30.1 | 12,522 | Common Stock |
| Merchants Bancorp | Patrick D. O'Brien | Director | Purchase of securities on an exchange or from another person at price $ 22.72 per share. | 13 Jun 2023 | 3,000 | 23,000 | - | 22.7 | 68,160 | Series A Preferred Stock |
| Merchants Bancorp | Patrick D. O'Brien | Director | Purchase of securities on an exchange or from another person at price $ 21.32 per share. | 13 Jun 2023 | 1,500 | 6,000 | - | 21.3 | 31,980 | Series B depositary shares |
| Merchants Bancorp | Patrick D. O'Brien | Director | Grant, award, or other acquisition of securities at price $ 23.80 per share. | 18 May 2023 | 526 | 114,374 (0%) | 0% | 23.8 | 12,519 | Common Stock |
| Greenlight Cap Re Ltd (Class A) | Patrick O'Brien | SEE REMARKS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2023 | 9,413 | 143,270 (0%) | 0% | 0 | CLASS A ORDINARY SHARES | |
| Merchants Bancorp | Patrick D. O'Brien | Director | Purchase of securities on an exchange or from another person at price $ 23.25 per share. | 09 Mar 2023 | 3,999 | 4,500 | - | 23.3 | 92,977 | Series B depositary shares |
| Merchants Bancorp | Patrick D. O'Brien | Director | Purchase of securities on an exchange or from another person at price $ 23.25 per share. | 07 Mar 2023 | 500 | 500 | - | 23.3 | 11,625 | Series B depositary shares |
| Merchants Bancorp | Patrick D. O'Brien | Director | Purchase of securities on an exchange or from another person at price $ 23.00 per share. | 07 Mar 2023 | 1 | 501 | - | 23 | 23 | Series B depositary shares |
| Merchants Bancorp | Patrick D. O'Brien | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 16 Feb 2023 | 80,000 | 40,000 | - | 0 | Series C Depositary Shares | |
| Merchants Bancorp | Patrick D. O'Brien | Director | Grant, award, or other acquisition of securities at price $ 30.63 per share. | 16 Feb 2023 | 409 | 113,848 (0%) | 0% | 30.6 | 12,528 | Common Stock |
| Arrowhead Pharma Inc | Patrick O'Brien | COO and General Counsel | Sale of securities on an exchange or to another person at price $ 37.39 per share. | 05 Jan 2023 | 7,500 | 413,375 (0%) | 0% | 37.4 | 280,425 | Common Stock |
| Arrowhead Pharma Inc | Patrick O'Brien | COO and General Counsel | Sale of securities on an exchange or to another person at price $ 37.39 per share. | 05 Jan 2023 | 7,500 | 420,875 (0%) | 0% | 37.4 | 280,425 | Common Stock |
| Arrowhead Pharma Inc | Patrick O'Brien | COO and General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 65,000 | 428,375 (0%) | 0% | 0 | Common Stock | |
| Arrowhead Pharma Inc | Patrick O'Brien | COO and General Counsel | Sale of securities on an exchange or to another person at price $ 38.54 per share. | 03 Jan 2023 | 5,527 | 372,695 (0%) | 0% | 38.5 | 213,011 | Common Stock |
| Arrowhead Pharma Inc | Patrick O'Brien | COO and General Counsel | Sale of securities on an exchange or to another person at price $ 38.58 per share. | 03 Jan 2023 | 5,286 | 363,945 (0%) | 0% | 38.6 | 203,934 | Common Stock |
| Arrowhead Pharma Inc | Patrick O'Brien | COO and General Counsel | Sale of securities on an exchange or to another person at price $ 37.58 per share. | 03 Jan 2023 | 2,894 | 369,231 (0%) | 0% | 37.6 | 108,757 | Common Stock |
| Arrowhead Pharma Inc | Patrick O'Brien | COO and General Counsel | Sale of securities on an exchange or to another person at price $ 37.53 per share. | 03 Jan 2023 | 2,653 | 378,222 (0%) | 0% | 37.5 | 99,567 | Common Stock |
| Arrowhead Pharma Inc | Patrick O'Brien | COO and General Counsel | Sale of securities on an exchange or to another person at price $ 39.74 per share. | 03 Jan 2023 | 500 | 372,195 (0%) | 0% | 39.7 | 19,870 | Common Stock |
| Arrowhead Pharma Inc | Patrick O'Brien | COO and General Counsel | Sale of securities on an exchange or to another person at price $ 39.55 per share. | 03 Jan 2023 | 300 | 363,645 (0%) | 0% | 39.6 | 11,865 | Common Stock |
| Arrowhead Pharma Inc | Patrick O'Brien | COO and General Counsel | Sale of securities on an exchange or to another person at price $ 40.53 per share. | 03 Jan 2023 | 270 | 363,375 (0%) | 0% | 40.5 | 10,943 | Common Stock |
| Arrowhead Pharma Inc | Patrick O'Brien | COO and General Counsel | Sale of securities on an exchange or to another person at price $ 40.80 per share. | 03 Jan 2023 | 70 | 372,125 (0%) | 0% | 40.8 | 2,856 | Common Stock |
| Arrowhead Pharma Inc | Patrick O'Brien | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.15 per share. | 21 Dec 2022 | 32,000 | 380,875 (0%) | 0% | 6.2 | 196,800 | Common Stock |
| Arrowhead Pharma Inc | Patrick O'Brien | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Dec 2022 | 32,000 | 0 | - | - | Stock Option (right to buy Common Stock) | |
| Merchants Bancorp | Patrick D. O'Brien | Director | Purchase of securities on an exchange or from another person at price $ 21.00 per share. | 09 Dec 2022 | 3,700 | 43,700 | - | 21 | 77,700 | Series C Depositary Shares |
| Cineverse Corp (Class A) | Patrick O'Brien | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Nov 2022 | 171,006 | 473,752 (0%) | 0% | 0 | Class A Common Stock | |
| Merchants Bancorp | Patrick D. O'Brien | Director | Grant, award, or other acquisition of securities at price $ 24.70 per share. | 16 Nov 2022 | 507 | 113,439 (0%) | 0% | 24.7 | 12,523 | Common Stock |
| Merchants Bancorp | Patrick D. O'Brien | Director | Purchase of securities on an exchange or from another person at price $ 25.00 per share. | 22 Sep 2022 | 40,000 | 40,000 | - | 25 | 1,000,000 | Series D Depositary Shares |
| Merchants Bancorp | Patrick D. O'Brien | Director | Grant, award, or other acquisition of securities at price $ 28.50 per share. | 18 Aug 2022 | 439 | 112,932 (0%) | 0% | 28.5 | 12,512 | Common Stock |
| Merchants Bancorp | Patrick D. O'Brien | Director | Grant, award, or other acquisition of securities at price $ 23.25 per share. | 19 May 2022 | 538 | 112,493 (0%) | 0% | 23.3 | 12,509 | Common Stock |
| Greenlight Cap Re Ltd (Class A) | Patrick O'Brien | SEE REMARKS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2022 | 16,781 | 133,857 (0%) | 0% | 0 | CLASS A ORDINARY SHARES | |
| Merchants Bancorp | Patrick D. O'Brien | Director | Grant, award, or other acquisition of securities at price $ 30.47 per share. | 17 Feb 2022 | 411 | 111,955 (0%) | 0% | 30.5 | 12,523 | Common Stock |
| Merchants Bancorp | Patrick D. O'Brien | Director | Grant, award, or other acquisition of securities at price $ 46.47 per share. | 17 Nov 2021 | 269 | 74,363 (0%) | 0% | 46.5 | 12,500 | Common Stock |
| Merchants Bancorp | Patrick D. O'Brien | Director | Grant, award, or other acquisition of securities at price $ 35.27 per share. | 19 Aug 2021 | 355 | 74,094 (0%) | 0% | 35.3 | 12,521 | Common Stock |
| Merchants Bancorp | Patrick D. O'Brien | Director | Grant, award, or other acquisition of securities at price $ 42.95 per share. | 20 May 2021 | 292 | 73,739 (0%) | 0% | 42.9 | 12,541 | Common Stock |
| Cineverse Corp (Class A) | Patrick O'Brien | Director | Sale of securities on an exchange or to another person at price $ 2.00 per share. | 25 Mar 2021 | 50,000 | 378,327 (0%) | 0% | 2.0 | 100,195 | Class A Common Stock |
| Cineverse Corp (Class A) | Patrick O'Brien | Director | Sale of securities on an exchange or to another person at price $ 2.02 per share. | 25 Mar 2021 | 6,298 | 328,327 (0%) | 0% | 2.0 | 12,692 | Class A Common Stock |
| Greenlight Cap Re Ltd (Class A) | Patrick O'Brien | SEE REMARKS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2021 | 30,501 | 117,076 (0%) | 0% | 0 | CLASS A ORDINARY SHARES |